XML 38 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Revenue
 6 Months Ended
Jun. 30, 2018
Revenue [Abstract]  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]
The cumulative effect of the changes made to our condensed consolidated January 1, 2018 balance sheet for the adoption of ASC 606 was as follows:
($ in millions)
Balance at December 31, 2017
 
Adjustments Due to ASC 606
 
Balance at January 1, 2018
Assets:
 
 
 
 
 
Accounts receivable, net
$
253.2

 
$
25.0

 
$
278.2

Inventories
215.2

 
(20.8
)
 
194.4

Other current assets
39.2

 
(8.4
)
 
30.8

 
 
 
 
 
 
Liabilities and Equity:
 
 
 
 
 
Other current liabilities
$
77.0

 
$
(13.7
)
 
$
63.3

Deferred income taxes
10.4

 
3.0

 
13.4

Other long-term liabilities
42.6

 
(4.9
)
 
37.7

Retained earnings
1,178.2

 
11.4

 
1,189.6

The impact of the adoption of ASC 606 on our condensed consolidated income statement for the three months ended June 30, 2018 was as follows:
($ in millions)
As Reported
 
Balances without Adoption of ASC 606
 
Effects of Change (Lower)/Higher
Net sales
$
447.5

 
$
452.6

 
$
(5.1
)
Cost of goods and services sold
305.3

 
305.9

 
(0.6
)
Research and development
10.8

 
10.9

 
(0.1
)
Other expense
1.1

 
0.9

 
0.2

Income tax expense
6.0

 
6.8

 
(0.8
)
Net income
$
56.1

 
$
59.9

 
$
(3.8
)
The impact of the adoption of ASC 606 on our condensed consolidated income statement for the six months ended June 30, 2018 was as follows:
($ in millions)
As Reported
 
Balances without Adoption of ASC 606
 
Effects of Change (Lower)/Higher
Net sales
$
863.2

 
$
870.9

 
$
(7.7
)
Cost of goods and services sold
586.6

 
588.6

 
(2.0
)
Research and development
20.4

 
20.5

 
(0.1
)
Other expense
4.2

 
3.9

 
0.3

Income tax expense
18.5

 
19.7

 
(1.2
)
Net income
$
99.7

 
$
104.4

 
$
(4.7
)
The impact of the adoption of ASC 606 on our condensed consolidated balance sheet as of June 30, 2018 was as follows:
($ in millions)
As Reported
 
Balances without Adoption of ASC 606
 
Effects of Change Higher/(Lower)
Assets:
 
 
 
 
 
Accounts receivable, net
$
296.7

 
$
276.8

 
$
19.9

Inventories
208.2

 
225.0

 
(16.8
)
Other current assets
36.5

 
46.1

 
(9.6
)
 
 
 
 
 
 
Liabilities and Equity:
 
 
 
 
 
Other current liabilities
$
86.2

 
$
96.5

 
$
(10.3
)
Deferred income taxes
11.8

 
10.0

 
1.8

Other long-term liabilities
42.4

 
47.1

 
(4.7
)
Retained earnings
1,258.0

 
1,251.3

 
6.7
Disaggregation of Revenue [Table Text Block]
The following table presents the approximate percentage of our net sales by market group:
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017 (1)
 
2018
 
2017 (1)
Biologics
21
%
 
23
%
 
22
%
 
23
%
Generics
21
%
 
20
%
 
21
%
 
20
%
Pharma
35
%
 
36
%
 
35
%
 
37
%
Contract-Manufactured Products
23
%
 
21
%
 
22
%
 
20
%
 
100
%
 
100
%
 
100
%
 
100
%
(1) As noted above, prior period amounts have not been adjusted under the modified retrospective method.
The following table presents the approximate percentage of our net sales by product category:
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017 (1)
 
2018
 
2017 (1)
High-Value Components
43
%
 
41
%
 
42
%
 
42
%
Standard Packaging
31
%
 
34
%
 
32
%
 
34
%
Delivery Devices
3
%
 
4
%
 
4
%
 
4
%
Contract-Manufactured Products
23
%
 
21
%
 
22
%
 
20
%
 
100
%
 
100
%
 
100
%
 
100
%
(1) As noted above, prior period amounts have not been adjusted under the modified retrospective method.
The following table presents the approximate percentage of our net sales by geographic location:
 
Three Months Ended
June 30,
 
Six Months Ended
June 30,
 
2018
 
2017 (1)
 
2018
 
2017 (1)
Americas
48
%
 
52
%
 
47
%
 
52
%
Europe, Middle East, Africa
44
%
 
41
%
 
45
%
 
41
%
Asia Pacific
8
%
 
7
%
 
8
%
 
7
%
 
100
%
 
100
%
 
100
%
 
100
%
(1) As noted above, prior period amounts have not been adjusted under the modified retrospective method.
Change in Contract with Customer, Asset and Liability [Abstract]
The following table summarizes our contract assets and liabilities, excluding contract assets included in accounts receivable, net:
 
($ in millions)
Contract assets, December 31, 2017
$
7.5

Contract assets, June 30, 2018
6.0

Change in contract assets - (decrease) increase
$
(1.5
)
 
 
Deferred income, December 31, 2017
$
(33.6
)
Deferred income, June 30, 2018
(24.2
)
Change in deferred income - decrease (increase)
$
9.4